ACC 22 Late-breaker Discussion: The DIAMOND Trial | with Dr Harriette Van Spall

Просмотров: 487   |   Загружено: 3 год.
icon
Radcliffe Cardiology
icon
3
icon
Скачать
iconПодробнее о видео
Watch the full video on Radcliffe Cardiology here:

Dr Harriette Van Spall (McMaster University, CA) talked with Prof Faiez Zannad (University of Lorraine, FR) and Dr Javed Butler (University of Mississippi & Baylor University Medical Center, US) about the DIAMOND trial in a context of RAAS inhibition in HFrEF (NCT03888066).
First presented first at ACC.22., the trial investigated the effects of patiromer compared with placebo on serum K+ in heart failure patients.

Recorded remotely in Texas, Hamilton and Nancy, 2022.
Editor: Mirjam Boros

This content is intended for healthcare professionals only.

Radcliffe brings medical knowledge, insight and innovation to life for CV clinicians around the world, using our communications & creative expertise, our platforms and connections across the community to help transform theory into practice faster.

Похожие видео

Добавлено: 55 год.
Добавил:
  © 2019-2021
  ACC 22 Late-breaker Discussion: The DIAMOND Trial | with Dr Harriette Van Spall - RusLar.Me